The JAK inhibitor pyridone 6 potently inhibits Th2 immunity and modestly inhibits Th1 responses, both of which are mediated through JAK/STAT signaling, which ameliorates AD-like skin inflammation [37]. This evidence concerns the gene SOAT1 and dermatitis.